期刊文献+

针对Egr-1mRNA的10-23脱氧核酶抑制大鼠动脉损伤后内膜增生的研究 被引量:2

Study on inhibiting intimal hyperplasia after vascular balloon injury in rats by 10-23 DNA enzyme targeting Egr-1mRNA
下载PDF
导出
摘要 目的探讨针对Egr-1mRNA的10-23脱氧核酶对大鼠动脉损伤后内膜增生的影响和可能的机制。方法制备大鼠颈动脉球囊损伤模型,96只大鼠随机分为4组,A组为假手术组;B组为1mmol/LMgCl2对照组;C组为FuGENE6对照组;D组为FuGENE6介导的ED5转染组;每组再按术后3,7,14和21d,分为4个亚组,每组6只。术后3、7、14、21d各处死每组动物6只,分别应用RT-PCR和Western-blot技术检测血管组织Egr-1mRNA水平及蛋白合成情况;HE染色观察损伤血管内膜的增生情况;免疫组织化学染色观察PCNA的表达。结果与B组和C组比较,D组各时间点血管内膜、中膜的厚度和管腔的狭窄率均显著减小(P<0.01);正常血管组织有微量Egr-1表达,术后Egr-1mRNA和蛋白水平逐渐增高,而D组血管组织E-gr-1mRNA和蛋白水平较B组和C组均降低(P<0.01);免疫组织化学染色显示,术后3dPCNA表达开始增加,7d达高峰,14d开始下降,D组血管壁PCNA阳性细胞百分比明显低于B组和C组(P<0.01)。B组和C组之间相比较,以上各指标差异均无显著性(P>0.05)。结论ED5可能通过抑制Egr-1和PCNA的表达,而减轻血管损伤后内膜增生。 [Objective] To investigate the effects of DNA enzyme targeting Egr-1mRNA (EDS) on intimal hyperplasia after vascular balloon injury and to primarily study its mechanism of inhibiting neointimal hyperplasia. [Methods] To establish the intimal injury model of left carotid artery in rats. Ninety-six rats were randomly divided into four groups, group A was sham-group; group B was MgCl2-eontrol group; group C was FuGENE6-eontrol group; group D was EDS-transfected group. MgCl2, FuGENE6 and ED5 was delivered the artery wall by the end of 2F balloon catheter. Six rats were killed at 3 d, 7 d, 14 d, 21 d after operation. Vascular sections stained with heamotoxylin and eosin to identify pathological changes of vascular by light microscope. Immunohistochemical staining for PCNA was performed. RT-PCR, western-blot methods were used to assay the changes of Egr-lmRNA expression and Egr-1 protein expression. [Results] Compared with group B and C, the intimal and media thickness and the stenosis rate of vessel in group D at every time points after operation was significantly less (P 〈0.01). There is less expression of Egr-1 in normal vascular wall. The expression of Egr-1 was up-regulated after operation. Com-pared with group B and C, the level of Egr-1 mRNA expression and Egr-1 protein in group D lowered in every time points(P 〈0.01 ), immunohistoehemieal staining exhibited PCNA-positive cells in group B and C were significantly more than those in group D (P 〈0.01). [Conclusion] ED5 can inhibit intimal hyperplasia after artery injury by decreasing the expression of Egr-1 and PCNA.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第12期1823-1827,1830,共6页 China Journal of Modern Medicine
基金 辽宁省教育厅高等学校科学技术研究项目(2004D185)
关键词 EGR-1 10-23脱氧核酶 血管损伤 内腱增生 Egr-1 10-23 DNA enzyme vascular injury intimal hyperplasia
  • 相关文献

参考文献10

  • 1孟磊,高炜,喻卓,郭艳红,田清平,赵春玉.甲氨蝶呤抑制兔颈动脉球囊损伤后新生内膜形成[J].中国介入心脏病学杂志,2005,13(1):45-48. 被引量:4
  • 2蒋健,舒强,凌光烈.弹性蛋白酶在球囊损伤后血管中膜平滑肌细胞迁徙中的作用(英文)[J].中国现代医学杂志,2003,13(21):44-47. 被引量:3
  • 3OHTANI K,EGASHIRA K,USUI M,et al.Inhibition of neointimal hyperplasia after balloon injury by cis-element □decoy' of early growth response gene-1 in hypercholesterolemic rabbits[J].Gene Therapy,2004,11(2):126-132.
  • 4WADA Y,SUZULI J,KAWAUCHI M,et al.Early growth response factor-1 and basic transcriptional element-binding protein2 expression in cardiac allografts[J].J Heart Lung Transplant,2001,20:590-594.
  • 5LOWE HC,FAHMY R C,KAVURMA MM,et al.Catalytic oligodcoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis[J].Circ Res,2001,89(12):670-677.
  • 6SANTIAGO FS,ATKINS DG,KHACHIGIAN LM,et al.Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent[J].Am J Path,1999,155(3):897-905.
  • 7毛华伟,赵晓东,杨锡强.脱氧核酶研究进展[J].中国生物工程杂志,2003,23(4):43-47. 被引量:5
  • 8KOUNDRIOUKOFF S,JONSSON ZO,HASAN S,et al.A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation[J].J Biol Chem,2000,275(30):22882-22887.
  • 9蔡尚郎,钟幼民,赵青,沃金善,徐传金.^(188)铼液体球囊血管内照射对细胞增殖、平滑肌细胞表型和转化生长因子的影响[J].中国介入心脏病学杂志,2005,13(4):251-254. 被引量:1
  • 10KHACHIGIAN LM.Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function[J].J Clin.Invest,2000,106(10):1189-1195.

二级参考文献59

  • 1Sugimoto N, Okumoto Y. Development of a short Ca^2+ -dependent deoxyribozyme with RNA cleaving activity. Nucleic Acids Symp Ser, 1999, (42) :281 - 281.
  • 2Both A, Breaker RR. An amio acid as a cofactor for a catalytic polynucleotide. Proc Natl Acad Sci USA, 1998,95 ( 11 ) : 6027 -6031.
  • 3Li Y, Breaker RR. Phosphorylating DNA with DNA. Proc Natl Acad Sci USA, 1999,96(6) :2746 - 2751.
  • 4Li Y, Liu Y, Breaker RR. Capping DNA with DNA. Biochemistry,2000,39(1) :3106 - 3114.
  • 5Carmi N, Breaker RR. Characterization of DNA-cleaving deoxyrihozyme. Bioorg Med Chem,2001,9(10) :2589 - 2600.
  • 6Travascio P, Bennet AJ, Wang DY,et al. A ribozyme and a catalytic DNA with peroxidase activity: active sites versus cofactor-binding sites. Chem Biol, 1999,6( 11 ) 779 - 787.
  • 7Li Y, Sen D. Toward an efficient DNAzyme. Biochemistry, 1997,36(18) :5589 - 5599.
  • 8Geyer CR, Sen D. Lanthanide probes for a phosphodiester-cleaving,lead-dependent,DNAzyme.J Mol Biol, 1998,275(3) :483 - 489.
  • 9Faulhmmer D, Famulok M. Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides. J Mol Biol, 1997,269(2) : 188 -202.
  • 10Geyer CR, Sen D. Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme. Chem Biol, 1997,4(8) :579 - 593.

共引文献9

同被引文献14

  • 1Li C, Cantor WJ, NiliN, et al. Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor[J]. Am Coll Cardiol, 2002, 39:1 852-858.
  • 2Zorio E, Gilabert-Estelles J, Espana F, et al. Fibrinolysis:the key to new pathogenetic mechanisms [ J ]. Curt Med Chem, 2008, 15 ( 9 ) : 923-927.
  • 3Sawa H, Lundgren C, Sobel BE, et al. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury : a potential progenitor of restenosis[J]. J Am Coll Cardiol, 1994, 24 (7) : 1 742-748.
  • 4Sakata K, Miura F, Sugino H, et al. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis[J]. Am Heart J, 1996, 131 (1): 1-6.
  • 5Ishiwata S, Tukuda T, Nakanishi S, et al. Postangioplasty restenosis: platelet activation and the coagulation - fibrinolysis system as possible factors in the pathogenesis of restenosis [ J ]. Am Heart J, 1997, 133 (4): 387-392.
  • 6Mao WH, Zhao XD, Yang XQ, et al. The latest developments of deoxyribozymes[J]. China Biotechnology, 2003, 23 (4) : 43-47.
  • 7Santiago FS, Lowe HC, Kavurma MM, et al. New DNAenzyme targeting Egr-I Mrna inhibits vascular smooth muscle proliferation and regrowth after injury[J]. Nat Med, 1999, 5 (11): 1 264-271.
  • 8Liu GN, Teng YX, Wu Y. Transfected synthetic DNA Enzyme Gene specifically inhibits Egr-1 gene expression and reduces neoiatimal hyperplasia following balloon injury in rats[J]. Int J Cardiol, 2008, 129 (1): 118-124.
  • 9Wu Y, Han W, Liu GN. A DNA Enzyme targeting Egr-1 inhibits rat vascular smooth muscle cell prol.iferation by down-regulation of cycliu DI and TGF-BI [J]. Braz J Med Biol Res, 2010, 43 (1) : 17-24.
  • 10Levon M, Khachigian. Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function[J]. J Clin Invest, 2000, 106 (10): 1 189-195.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部